220 related articles for article (PubMed ID: 23376559)
1. Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers.
Chaudhary H; Rohilla A; Rathee P; Kumar V
Int J Biol Macromol; 2013 Apr; 55():246-53. PubMed ID: 23376559
[TBL] [Abstract][Full Text] [Related]
2. Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design.
Chaudhary H; Kohli K; Amin S; Rathee P; Kumar V
J Pharm Sci; 2011 Feb; 100(2):580-93. PubMed ID: 20669331
[TBL] [Abstract][Full Text] [Related]
3. Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design.
Shi J; Ma F; Wang X; Wang F; Liao H
J Liposome Res; 2012 Dec; 22(4):270-8. PubMed ID: 22676370
[TBL] [Abstract][Full Text] [Related]
4. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
[TBL] [Abstract][Full Text] [Related]
5. Nano-transfersomes as a novel carrier for transdermal delivery.
Chaudhary H; Kohli K; Kumar V
Int J Pharm; 2013 Sep; 454(1):367-80. PubMed ID: 23871739
[TBL] [Abstract][Full Text] [Related]
6. Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases.
A-sasutjarit R; Sirivat A; Vayumhasuwan P
Pharm Res; 2005 Dec; 22(12):2134-40. PubMed ID: 16215775
[TBL] [Abstract][Full Text] [Related]
7. Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers.
Hashmat D; Shoaib MH; Ali FR; Siddiqui F
PLoS One; 2020; 15(2):e0228908. PubMed ID: 32107483
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer.
Al-Suwayeh SA; Taha EI; Al-Qahtani FM; Ahmed MO; Badran MM
ScientificWorldJournal; 2014; 2014():127495. PubMed ID: 25045724
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
10. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
11. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment.
Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S
AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380
[TBL] [Abstract][Full Text] [Related]
12. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
[TBL] [Abstract][Full Text] [Related]
13. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell.
Sivaraman A; Banga AK
J Pharm Pharmacol; 2016 Jan; 68(1):26-35. PubMed ID: 26714423
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
16. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design.
Solanki AB; Parikh JR; Parikh RH
AAPS PharmSciTech; 2007 Oct; 8(4):E86. PubMed ID: 18181547
[TBL] [Abstract][Full Text] [Related]
17. Meloxicam carbopol-based gels: characterization and evaluation.
Sareen R; Kumar S; Gupta GD
Curr Drug Deliv; 2011 Jul; 8(4):407-15. PubMed ID: 21453256
[TBL] [Abstract][Full Text] [Related]
18. Preparation and optimization of fisetin loaded glycerol based soft nanovesicles by Box-Behnken design.
Moolakkadath T; Aqil M; Ahad A; Imam SS; Praveen A; Sultana Y; Mujeeb M
Int J Pharm; 2020 Mar; 578():119125. PubMed ID: 32036010
[TBL] [Abstract][Full Text] [Related]
19. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
Shahzad Y; Khan Q; Hussain T; Shah SN
Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
[TBL] [Abstract][Full Text] [Related]
20. Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II.
Hussain A; Haque MW; Singh SK; Ahmed FJ
Drug Deliv; 2016 May; 23(4):1242-53. PubMed ID: 26697777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
